Fact based stock research
Steris (NYSE:STE)


Steris stock research in summary

steris.com


Steris shares have a HOLD rating. While they are good value, they show below average growth, and are riskily financed. We recommend holding Steris shares.


Latest Obermatt Ranks


Country United Kingdom
Industry Health Care Equipment
Index S&P MIDCAP, D.J. US Medical Equipment
Size class Large

June 8, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Achievements

Top 10 Stock



Research History: Steris

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
65
78
76
90
STOCK GROWTH RANKS
45
95
19
38
STOCK SAFETY RANKS
18
18
5
26
COMBINED STOCK RANKS
29
75
59
62

Last update of Combined Rank: 8-Jun-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is Steris in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 8-Jun-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Steris; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
59
88
17
25
PROFIT GROWTH
33
72
66
35
STOCK RETURNS
57
47
63
77
CONSOLIDATED RANK: GROWTH
45
95
19
38

Financial reporting date of Growth Rank: 31-Mar-2018. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Steris.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
17
12
24
18
REFINANCING
46
46
35
33
LIQUIDITY
47
51
61
53
CONSOLIDATED RANK: SAFETY
18
18
5
26

Financial reporting date of Safety Rank: 31-Mar-2018. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Steris and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Steris from June 8, 2018.